Literature DB >> 25509295

[Chemical constituents from safflower injection and their bioactivity].

Jian-Feng Zhao, Jing Liu, Ying Guo, Qian Liu, Zhong Dai, Shuang-Cheng Ma, Rui-Chao Lin.   

Abstract

The chemical constituents of Safflower injection were isolated and purified by polyamide, silica gel, Sephadex LH-20, ODS column chromatographies and preparative HPLC. As a result, sixteen compounds have been isolated. Based on the spectral data analysis, their structures were elucidated as scutellarin (1), kaempferol-3-O-β-rutinoside(2), hydroxysafflor yellow A(3), rutin (4), coumalic acid(5), adenosine(6), syringoside(7), (3E)-4-(4'-hydroxyphenyl)-3-buten-2-one(8), (8Z)-decaene-4, 6-diyne-1-Oβ-D-glucopyranoside(9), 4-hydroxybenzaldehyde (10), (2E, 8E) -tetradecadiene-4, 6-diyne-1, 12, 14-triol-1-O-β-D-glucopyranoside (11), kaem-pferol-3-O-β-sophorose (12), uridine (13), roseoside (14), cinnamic acid (15), and kaempferol (16). Compounds 1,2,7,9,11 and 12 were isolated from the Safflower injection for the first time. The anti-platelet aggregation activities of the isolated compounds were assayed. The results indicated all tested compounds exhibited potent activity except for 5, while 2, 3, 9 and 12 showed strong activity against platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25509295

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride.

Authors:  Yanuo Li; Yan Shi; Yan Sun; Luying Liu; Xianyong Bai; Dong Wang; Hongxing Li
Journal:  Mol Med Rep       Date:  2016-11-24       Impact factor: 2.952

2.  Comparison of Inhibitory Effects of Safflower Decoction and Safflower Injection on Protein and mRNA Expressions of iNOS and IL-1β in LPS-Activated RAW264.7 Cells.

Authors:  Hui Liao; Yuanping Li; Xiaoru Zhai; Bin Zheng; Linda Banbury; Xiaoyun Zhao; Rongshan Li
Journal:  J Immunol Res       Date:  2019-05-06       Impact factor: 4.818

3.  Therapeutic Efficacy and Safety of Safflower Injection in the Treatment of Acute Coronary Syndrome.

Authors:  Qiang Lu; Jiamin Xu; Qian Li; Wenzhen Wu; Yuling Wu; Jianhui Xie; Xiaobo Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-16       Impact factor: 2.629

4.  In Vitro Anticoagulant Activity and Active Components of Safflower Injection.

Authors:  Kai-Hong Wang; Shi-Fei Li; Yi Zhao; Hong-Xia Li; Li-Wei Zhang
Journal:  Molecules       Date:  2018-01-15       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.